Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients

医学 肺栓塞 内科学 回顾性队列研究 入射(几何) 危险系数 肺炎 急诊医学 血栓形成 静脉血栓形成 深静脉 置信区间 光学 物理
作者
Vincent Lo Re,Sarah K. Dutcher,John G. Connolly,Silvia Pérez-Vilar,Dena M. Carbonari,Terese A. DeFor,Djeneba Audrey Djibo,Laura B. Harrington,Laura Hou,Sean Hennessy,Rebecca A. Hubbard,Maria E. Kempner,Jennifer L. Kuntz,Cheryl N. McMahill‐Walraven,Jolene Mosley,Pamala A. Pawloski,Andrew B. Petrone,Allyson M. Pishko,Meighan Rogers Driscoll,Claudia Steiner
出处
期刊:JAMA [American Medical Association]
卷期号:328 (7): 637-637 被引量:90
标识
DOI:10.1001/jama.2022.13072
摘要

Importance: The incidence of arterial thromboembolism and venous thromboembolism in persons with COVID-19 remains unclear. Objective: To measure the 90-day risk of arterial thromboembolism and venous thromboembolism in patients hospitalized with COVID-19 before or during COVID-19 vaccine availability vs patients hospitalized with influenza. Design, Setting, and Participants: Retrospective cohort study of 41 443 patients hospitalized with COVID-19 before vaccine availability (April-November 2020), 44 194 patients hospitalized with COVID-19 during vaccine availability (December 2020-May 2021), and 8269 patients hospitalized with influenza (October 2018-April 2019) in the US Food and Drug Administration Sentinel System (data from 2 national health insurers and 4 regional integrated health systems). Exposures: COVID-19 or influenza (identified by hospital diagnosis or nucleic acid test). Main Outcomes and Measures: Hospital diagnosis of arterial thromboembolism (acute myocardial infarction or ischemic stroke) and venous thromboembolism (deep vein thrombosis or pulmonary embolism) within 90 days. Outcomes were ascertained through July 2019 for patients with influenza and through August 2021 for patients with COVID-19. Propensity scores with fine stratification were developed to account for differences between the influenza and COVID-19 cohorts. Weighted Cox regression was used to estimate the adjusted hazard ratios (HRs) for outcomes during each COVID-19 vaccine availability period vs the influenza period. Results: A total of 85 637 patients with COVID-19 (mean age, 72 [SD, 13.0] years; 50.5% were male) and 8269 with influenza (mean age, 72 [SD, 13.3] years; 45.0% were male) were included. The 90-day absolute risk of arterial thromboembolism was 14.4% (95% CI, 13.6%-15.2%) in patients with influenza vs 15.8% (95% CI, 15.5%-16.2%) in patients with COVID-19 before vaccine availability (risk difference, 1.4% [95% CI, 1.0%-2.3%]) and 16.3% (95% CI, 16.0%-16.6%) in patients with COVID-19 during vaccine availability (risk difference, 1.9% [95% CI, 1.1%-2.7%]). Compared with patients with influenza, the risk of arterial thromboembolism was not significantly higher among patients with COVID-19 before vaccine availability (adjusted HR, 1.04 [95% CI, 0.97-1.11]) or during vaccine availability (adjusted HR, 1.07 [95% CI, 1.00-1.14]). The 90-day absolute risk of venous thromboembolism was 5.3% (95% CI, 4.9%-5.8%) in patients with influenza vs 9.5% (95% CI, 9.2%-9.7%) in patients with COVID-19 before vaccine availability (risk difference, 4.1% [95% CI, 3.6%-4.7%]) and 10.9% (95% CI, 10.6%-11.1%) in patients with COVID-19 during vaccine availability (risk difference, 5.5% [95% CI, 5.0%-6.1%]). Compared with patients with influenza, the risk of venous thromboembolism was significantly higher among patients with COVID-19 before vaccine availability (adjusted HR, 1.60 [95% CI, 1.43-1.79]) and during vaccine availability (adjusted HR, 1.89 [95% CI, 1.68-2.12]). Conclusions and Relevance: Based on data from a US public health surveillance system, hospitalization with COVID-19 before and during vaccine availability, vs hospitalization with influenza in 2018-2019, was significantly associated with a higher risk of venous thromboembolism within 90 days, but there was no significant difference in the risk of arterial thromboembolism within 90 days.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
渔舟完成签到 ,获得积分10
刚刚
马赛克完成签到,获得积分10
1秒前
荼蘼发布了新的文献求助10
1秒前
英俊的铭的应助被忧郁背包采纳,获得10
2秒前
海鲸完成签到,获得积分10
2秒前
bqys的应助被岳老师采纳,获得10
2秒前
3秒前
深情安青的应助被Eli采纳,获得10
3秒前
如约而至完成签到,获得积分10
4秒前
null的应助被墨北弋采纳,获得10
4秒前
所所的应助被wlei采纳,获得10
4秒前
4秒前
LL路完成签到 ,获得积分10
5秒前
5秒前
xlanister完成签到,获得积分20
5秒前
xzp发布了新的文献求助10
6秒前
moexce完成签到,获得积分10
6秒前
6秒前
7秒前
尘_完成签到,获得积分10
7秒前
8秒前
8秒前
9秒前
隐形曼青的应助被忐忑的白凡采纳,获得10
9秒前
9秒前
YutingLiu0101完成签到,获得积分10
9秒前
Jasper的应助被100采纳,获得10
10秒前
浮晓发布了新的文献求助10
11秒前
11秒前
BLUE发布了新的文献求助10
11秒前
ubless607的应助被咎如天采纳,获得10
12秒前
12秒前
荼蘼发布了新的文献求助10
12秒前
Wu完成签到,获得积分20
12秒前
xi完成签到,获得积分10
13秒前
13秒前
syvshc的应助被Serendipity采纳,获得10
13秒前
溺水小刀发布了新的文献求助10
13秒前
14秒前
张伟发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241